You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201881 - 201890 of 207699 results
  1. N/A

    SBC: PROLONG PHARMACEUTICALS, INC.            Topic: N/A

    Location 300B Corporate Court South Plainfield, NJ 07080 United States N44HB0900038 $798 165.00 2 008 N/A Department of Health and Human Services National Institutes of Health SBIR PHS2009-1 PROLONG PHARMACEUTICALS, INC. Phase II N44HB0900038 1 ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  2. SBIR PHASE II TOPIC 37

    SBC: LUNA INNOVATIONS INCORPORATED            Topic: N/A

    Location 301 1ST STREET SW, SUITE 200 ROANOKE, VA 24011 United States N44HV0900023 $200 000.00 2 009 SBIR PHASE II TOPIC 37 Department of Health and Human Services National Institutes of Health SBIR PHS2009-1 LUNA INNOVATIONS INCORPORATED Phase II N44HV09 ...

    SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  3. CNS Stem Cells for Alzheimer's Disease Therapy

    SBC: STEMCELLS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a progressive neurodegenerative disease. It is prevalent among the elderly, affecting approximately 4 million Americans. Alzheimer's is a heterogeneous disease involving a number of comp

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  4. A Peptide-Based Vaccine to Nicotine

    SBC: Prommune, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The primary objective of this Phase I STTR project is to develop an effective, peptide-based nicotine vaccine for use in humans capable of inducing a robust, nicotine-specific antibody (Ab) response with little or no i

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  5. Cytochlor/cytofluor: New Tumor Targeted Radiosensitizer

    SBC: HALOGENETICS            Topic: N/A

    DESCRIPTION (provided by applicant): Cytochlor Technology is about to enter a Phase I trial as a radiosensitizer of tumors of the oral cavity and oropharynx with NCI supervision. Our objective is to demonstrate Cytochlor's safety, selectivity and possi

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  6. GENETIC DIAGNOSTIC TEST FOR ESSENTIAL HYPERTENSION

    SBC: HYPOGEN, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Essential hypertension, or elevated blood pressure of unknown etiology, is responsible for more morbidity and mortality than the top five leading diseases. However, no diagnostic test exists for the prediction of e

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  7. Application of plant genomics to alcoholic brain damage

    SBC: NAPROGENIX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Alcoholic liver damage (ALD) is among the ten most common causes of death in the USA. The liver may be uniquely sensitive because it metabolizes ethanol at a high rate. This generates acetaldehyde intracellularly,

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  8. Methods for Improving Pancreatic Islet Transplantation

    SBC: Synthecon, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Transplantation of islets of Langerhans has long held promise as a cure for Type 1 diabetes mellitus. In the past, most islet transplants failed to achieve insulin independence. Recently, a new immunosuppressan

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  9. A NOVEL ADJUVANT FOR TUMQR VACCINATION

    SBC: APOIMMUNE, INC            Topic: N/A

    DESCRIPTION (provided by applicant): Cancer continues to be a leading cause of death in the U.S. and in many other countries. Cancers develop and spread within the body when tumor cells are not detected or destroyed by the immune system. Although cer

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Novel Tool Compounds for Chromatin Research

    SBC: UPSTATE USA, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): A Phase 1 STTR proposal seeks to identify and develop novel compounds that target chromatin regulatory proteins. A yeast-based assay will be used to screen the National Cancer Institute Diversity Set library of small m

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government